<VariationArchive VariationID="279852" VariationName="NM_001370259.2(MEN1):c.1546dup (p.Arg516fs)" VariationType="Duplication" Accession="VCV000279852" Version="49" RecordType="classified" NumberOfSubmissions="12" NumberOfSubmitters="11" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="264436" VariationID="279852">
      <GeneList>
        <Gene Symbol="MEN1" FullName="menin 1" GeneID="4221" HGNC_ID="HGNC:7010" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="64803516" stop="64811294" display_start="64803516" display_stop="64811294" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="64570985" stop="64578765" display_start="64570985" display_stop="64578765" Strand="-" />
          </Location>
          <OMIM>613733</OMIM>
          <Haploinsufficiency last_evaluated="2022-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MEN1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MEN1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2022</Property>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
        </Gene>
      </GeneList>
      <Name>NM_001370259.2(MEN1):c.1546dup (p.Arg516fs)</Name>
      <CanonicalSPDI>NC_000011.10:64804620:GGGGGGG:GGGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11q13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="64804620" stop="64804621" display_start="64804620" display_stop="64804621" variantLength="1" positionVCF="64804620" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="64572092" stop="64572093" display_start="64572092" display_stop="64572093" variantLength="1" positionVCF="64572092" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <OtherNameList>
        <Name>1657insC</Name>
      </OtherNameList>
      <ProteinChange>R481fs</ProteinChange>
      <ProteinChange>R521fs</ProteinChange>
      <ProteinChange>R558fs</ProteinChange>
      <ProteinChange>R516fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130799.2" sequenceAccession="NM_130799" sequenceVersion="2" change="c.1546dupC">
            <Expression>NM_130799.2:c.1546dupC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.64804627dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.64804627dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.64572099dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.64572099dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008929.1" sequenceAccession="NG_008929" sequenceVersion="1" change="g.11674dup">
            <Expression>NG_008929.1:g.11674dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033040.1" sequenceAccession="NG_033040" sequenceVersion="1" change="g.3621dup">
            <Expression>NG_033040.1:g.3621dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000244.4" sequenceAccession="NM_000244" sequenceVersion="4" change="c.1561dup">
            <Expression>NM_000244.4:c.1561dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000235.3" sequenceAccession="NP_000235" sequenceVersion="3" change="p.Arg521fs">
            <Expression>NP_000235.3:p.Arg521fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370251.2" sequenceAccession="NM_001370251" sequenceVersion="2" change="c.1672dup">
            <Expression>NM_001370251.2:c.1672dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357180.2" sequenceAccession="NP_001357180" sequenceVersion="2" change="p.Arg558fs">
            <Expression>NP_001357180.2:p.Arg558fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370259.2" sequenceAccession="NM_001370259" sequenceVersion="2" change="c.1546dup" MANESelect="true">
            <Expression>NM_001370259.2:c.1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357188.2" sequenceAccession="NP_001357188" sequenceVersion="2" change="p.Arg516fs">
            <Expression>NP_001357188.2:p.Arg516fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370260.2" sequenceAccession="NM_001370260" sequenceVersion="2" change="c.1546dup">
            <Expression>NM_001370260.2:c.1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357189.2" sequenceAccession="NP_001357189" sequenceVersion="2" change="p.Arg516fs">
            <Expression>NP_001357189.2:p.Arg516fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370261.2" sequenceAccession="NM_001370261" sequenceVersion="2" change="c.1546dup">
            <Expression>NM_001370261.2:c.1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357190.2" sequenceAccession="NP_001357190" sequenceVersion="2" change="p.Arg516fs">
            <Expression>NP_001357190.2:p.Arg516fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370262.2" sequenceAccession="NM_001370262" sequenceVersion="2" change="c.1441dup">
            <Expression>NM_001370262.2:c.1441dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357191.2" sequenceAccession="NP_001357191" sequenceVersion="2" change="p.Arg481fs">
            <Expression>NP_001357191.2:p.Arg481fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370263.2" sequenceAccession="NM_001370263" sequenceVersion="2" change="c.1441dup">
            <Expression>NM_001370263.2:c.1441dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357192.2" sequenceAccession="NP_001357192" sequenceVersion="2" change="p.Arg481fs">
            <Expression>NP_001357192.2:p.Arg481fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130799.3" sequenceAccession="NM_130799" sequenceVersion="3" change="c.1546dup">
            <Expression>NM_130799.3:c.1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570711.2" sequenceAccession="NP_570711" sequenceVersion="2" change="p.Arg516fs">
            <Expression>NP_570711.2:p.Arg516fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130800.3" sequenceAccession="NM_130800" sequenceVersion="3" change="c.1561dup">
            <Expression>NM_130800.3:c.1561dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570712.2" sequenceAccession="NP_570712" sequenceVersion="2" change="p.Arg521fs">
            <Expression>NP_570712.2:p.Arg521fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130801.3" sequenceAccession="NM_130801" sequenceVersion="3" change="c.1561dup">
            <Expression>NM_130801.3:c.1561dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570713.2" sequenceAccession="NP_570713" sequenceVersion="2" change="p.Arg521fs">
            <Expression>NP_570713.2:p.Arg521fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130802.3" sequenceAccession="NM_130802" sequenceVersion="3" change="c.1561dup">
            <Expression>NM_130802.3:c.1561dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570714.2" sequenceAccession="NP_570714" sequenceVersion="2" change="p.Arg521fs">
            <Expression>NP_570714.2:p.Arg521fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130803.3" sequenceAccession="NM_130803" sequenceVersion="3" change="c.1561dup">
            <Expression>NM_130803.3:c.1561dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570715.2" sequenceAccession="NP_570715" sequenceVersion="2" change="p.Arg521fs">
            <Expression>NP_570715.2:p.Arg521fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_130804.3" sequenceAccession="NM_130804" sequenceVersion="3" change="c.1561dup">
            <Expression>NM_130804.3:c.1561dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_570716.2" sequenceAccession="NP_570716" sequenceVersion="2" change="p.Arg521fs">
            <Expression>NP_570716.2:p.Arg521fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_509" sequenceAccession="LRG_509">
            <Expression>LRG_509:g.11674dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_509t2" sequenceAccession="LRG_509t2">
            <Expression>LRG_509t2:c.1546dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_509p2" sequenceAccession="LRG_509p2" change="p.Arg516fs">
            <Expression>LRG_509p2:p.Arg516fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA6082217" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="613733.0015" DB="OMIM" />
        <XRef Type="Allelic variant" ID="613733.0033" DB="OMIM" />
        <XRef Type="rs" ID="767319284" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff determined the location of this allele from the gel in Figure 2 of the paper by Debelenko et al., 1997 (PubMed 9361035).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001370259.2(MEN1):c.1546dup (p.Arg516fs) AND Lung carcinoid tumor" Accession="RCV000018171" Version="11">
        <ClassifiedConditionList TraitSetID="5473">
          <ClassifiedCondition DB="MedGen" ID="C0280089">Lung carcinoid tumor</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001370259.2(MEN1):c.1546dup (p.Arg516fs) AND not provided" Accession="RCV000269197" Version="37">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-03-20" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001370259.2(MEN1):c.1546dup (p.Arg516fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV000491230" Version="13">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001370259.2(MEN1):c.1546dup (p.Arg516fs) AND Multiple endocrine neoplasia, type 1" Accession="RCV000548407" Version="24">
        <ClassifiedConditionList TraitSetID="5472">
          <ClassifiedCondition DB="MedGen" ID="C0025267">Multiple endocrine neoplasia, type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-16" SubmissionCount="6">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-16" NumberOfSubmissions="12" NumberOfSubmitters="11" DateCreated="2013-04-04" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11303512</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11579199</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12112656</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12213668</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14985373</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15240620</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15635078</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15670192</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17065424</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17623761</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17853334</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17879353</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19041010</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20833329</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21340156</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22470073</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23321498</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24915123</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25291050</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29036195</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30324798</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30339208</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32299109</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34160414</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">35696052</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9215689</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9361035</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9463336</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9709921</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5472" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="12656" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MEA I</ElementValue>
                <XRef Type="MIM" ID="131100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Endocrine adenomatosis multiple</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MEN 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Wermer syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Multiple endocrine neoplasia, type 1</ElementValue>
                <XRef ID="Multiple+endocrine+neoplasia+type+1/4955" DB="Genetic Alliance" />
                <XRef ID="30664006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MEN I</ElementValue>
                <XRef Type="MIM" ID="131100" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MEN1</ElementValue>
                <XRef Type="MIM" ID="131100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Multiple endocrine neoplasia type 1 (MEN1) includes varying combinations of more than 20 endocrine and non-endocrine tumors. Endocrine tumors become evident either by overproduction of hormones by the tumor or by growth of the tumor itself. Parathyroid tumors are the most common MEN1-associated endocrinopathy; onset in 90% of individuals is between ages 20 and 25 years with hypercalcemia evident by age 50 years; hypercalcemia causes lethargy, depression, confusion, anorexia, constipation, nausea, vomiting, diuresis, dehydration, hypercalciuria, kidney stones, increased bone resorption/fracture risk, hypertension, and shortened QT interval. Pituitary tumors include prolactinoma (the most common), which manifests as oligomenorrhea/amenorrhea and galactorrhea in females and sexual dysfunction in males. Well-differentiated endocrine tumors of the gastro-entero-pancreatic (GEP) tract can manifest as Zollinger-Ellison syndrome (gastrinoma); hypoglycemia (insulinoma); hyperglycemia, anorexia, glossitis, anemia, diarrhea, venous thrombosis, and skin rash (glucagonoma); and watery diarrhea, hypokalemia, and achlorhydria syndrome (vasoactive intestinal peptide [VIP]-secreting tumor). Carcinoid tumors are non-hormone-secreting and can manifest as a large mass after age 50 years. Adrenocortical tumors can be associated with primary hypercortisolism or hyperaldosteronism. Non-endocrine tumors include facial angiofibromas, collagenomas, lipomas, meningiomas, ependymomas, and leiomyomas.</Attribute>
                <XRef ID="NBK1538" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3829" />
                <XRef ID="3829" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301710</ID>
                <ID Source="BookShelf">NBK1538</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2010">
                <ID Source="PubMed">20065170</ID>
              </Citation>
              <Citation Type="general" Abbrev="Brandi et al., 2001">
                <ID Source="PubMed">11739416</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="Thakker et al., 2012">
                <ID Source="PubMed">22723327</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Endocrine and Neuroendocrine Neoplasia genetics">
                <ID Source="PubMed">26389271</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Breast and Gynecologic Cancers">
                <ID Source="PubMed">26389210</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2015">
                <ID Source="PubMed">26324357</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Neuroendocrine and Adrenal Tumors, 2023</CitationText>
              </Citation>
              <XRef ID="652" DB="Orphanet" />
              <XRef ID="C0025267" DB="MedGen" />
              <XRef ID="D018761" DB="MeSH" />
              <XRef ID="MONDO:0007540" DB="MONDO" />
              <XRef Type="MIM" ID="131100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5473" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="12657" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Lung carcinoid tumor</ElementValue>
                <XRef ID="HP:0030445" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0006041" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pulmonary carcinoid tumor</ElementValue>
                <XRef ID="HP:0030445" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carcinoid tumor of lung</ElementValue>
              </Name>
              <XRef ID="C0280089" DB="MedGen" />
              <XRef ID="MONDO:0006041" DB="MONDO" />
              <XRef Type="primary" ID="HP:0030445" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="38450" SubmissionDate="2012-11-28" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613733.0015_CARCINOID TUMOR OF LUNG" title="MEN1, 1-BP INS, 1650C_CARCINOID TUMOR OF LUNG" />
        <ClinVarAccession Accession="SCV000038450" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Lung carcinoids occur sporadically and rarely in association with MEN1 (see 131100). Debelenko et al. (1997) studied 11 sporadic lung carcinoids for LOH in 1 locus and for mutations of the MEN1 gene using dideoxy fingerprinting. Additionally, a lung carcinoid from an MEN1 patient was studied. In 4 of 11 (36%) sporadic tumors, both copies of the MEN1 gene were inactivated. All 4 tumors showed the presence of a MEN1 gene mutation and loss of the other allele. Observed mutations included a 1-bp insertion (1650insC) , a 1-bp deletion, a 13-bp deletion, and a single nucleotide substitution affecting a donor splice site. Each mutation predicted truncation or potentially complete loss of MEN1. The remaining 7 tumors showed neither the presence of a MEN1 gene mutation nor 11q13 LOH. The tumor from the MEN1 patient showed LOH at 11q13 and a complex germline MEN1 gene mutation. The findings of this study represented the first defined genetic alteration in carcinoids.</Attribute>
              <Citation>
                <ID Source="PubMed">9361035</ID>
              </Citation>
              <XRef DB="OMIM" ID="131100" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <Name>MEN1, 1-BP INS, 1650C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1650C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613733.0015" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CARCINOID TUMOR OF LUNG</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="38468" SubmissionDate="2017-02-21" DateLastUpdated="2017-02-25" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613733.0033_MULTIPLE ENDOCRINE NEOPLASIA, TYPE I" title="MEN1, 1-BP INS, 1657C_MULTIPLE ENDOCRINE NEOPLASIA, TYPE I" />
        <ClinVarAccession Accession="SCV000038468" DateUpdated="2017-02-25" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Ebeling et al. (2004) used church records and MEN1 (131100) family information to detect founder couples for the 2 prevailing mutations in Northern Finland, 1466del12 (613733.0032) and 1657insC. Four families with the 1657incC mutation could be traced back to a couple living 200 kilometers northeast of Oulu born in 1844 and 1846, and not farther than only 4 generations from the youngest. The authors noted that while the most prevalent mutation (1466del12; 613733.0032) is a unique Finnish mutation, the 1657delC mutation seems to be a hotspot, as it has been found in 5 different MEN1 populations (Guo and Sawicki, 2001).</Attribute>
              <Citation>
                <ID Source="PubMed">15240620</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11579199</ID>
              </Citation>
              <XRef DB="OMIM" ID="131100" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <Name>MEN1, 1-BP INS, 1657C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1657C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613733.0033" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MULTIPLE ENDOCRINE NEOPLASIA, TYPE I</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1524308" SubmissionDate="2017-12-20" DateLastUpdated="2018-07-07" DateCreated="2018-07-07">
        <ClinVarSubmissionID localKey="MEN1-A9|MedGen:C0025267" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000781725" DateUpdated="2018-07-07" DateCreated="2018-07-07" Type="SCV" Version="1" SubmitterName="Center for Human Genetics, Inc, Center for Human Genetics, Inc" OrgID="1024" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130799.2:c.1546dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0025267" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3363248</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="642684" SubmissionDate="2022-06-15" DateLastUpdated="2023-03-04" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="GDXSV:230069" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000329424" DateUpdated="2023-03-04" DateCreated="2016-12-06" Type="SCV" Version="8" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate a damaging effect: impaired nuclear localization of protein compared to wild-type (Ikeo 1999); Not observed at significant frequency in large population cohorts (gnomAD); Also known as c.1561dup, c.1650insC, c.1657insC, and c.7773insC; This variant is associated with the following publications: (PMID: 9463336, 11836268, 20660572, 28701629, 9361035, 10993647, 17879353, 17065424, 15714081, 12652570, 10576763, 10812010, 10849016, 9709921, 12050235, 14985373, 11058905, 11524904, 15670192, 12112656, 9747036, 21340156, 27038812, 11034102, 15240620, 11303512, 19041010, 25291050, 9215689, 15635078, 9683585, 15730416, 22470073, 29036195, 30324798, 20367983, 12213668, 17853334, 23321498, 24915123, 10595737, 34160414)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:33309</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130799.2:c.1546dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_112_20220615054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1220277" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2017-12-26">
        <ClinVarSubmissionID localKey="1437757|MedGen:C0025267" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000628059" DateUpdated="2024-02-28" DateCreated="2017-12-26" Type="SCV" Version="9" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9215689</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15635078</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21340156</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22470073</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24915123</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25291050</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9215689</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12112656</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12213668</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15670192</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17065424</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17853334</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23321498</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg516Profs*15) in the MEN1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 95 amino acid(s) of the MEN1 protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with multiple endocrine neoplasia type 1 (PMID: 9215689, 15635078, 21340156, 22470073, 24915123, 25291050). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is also known as c.1650insC, c.1561dup (p.Arg521fs), c.1561dupC, and c.1546dupC.. ClinVar contains an entry for this variant (Variation ID: 279852). This variant disrupts a region of the MEN1 protein in which other variant(s) (p.Arg516Glyfs*43) have been determined to be pathogenic (PMID: 9215689, 12112656, 12213668, 15670192, 17065424, 17853334, 23321498). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.64572092_64572093insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0025267" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1129376" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2017-06-25">
        <ClinVarSubmissionID localKey="a8746|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000579621" DateUpdated="2024-05-01" DateCreated="2017-06-25" Type="SCV" Version="7" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15635078</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17879353</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19041010</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21340156</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29036195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9215689</ID>
          </Citation>
          <Comment>The c.1546dupC pathogenic mutation, located in coding exon 9 of the MEN1 gene, results from a duplication of C at nucleotide position 1546, causing a translational frameshift with a predicted alternate stop codon (p.R516Pfs*15). This mutation has been reported in several families affected with multiple endocrine neoplasia type 1 (MEN1) (Zha BB et al. Chinese Med J. 2010;123(5):569-573; Pieterman CR et al. Ann Surg. 2012 Jun;255(6):1171-8; Cardinal JW et al. J. Med. Genet., 2005 Jan;42:69-74; Pardi E et al. PLoS ONE. 2017 Oct;12(10):e0186485). This mutation was also reported in an early onset sporadic case of MEN1 (Boguszewski CL et al. Arq Bras Endocrinol Metabol. 2010 Nov;54(8):705-10) and in a patient with primary hyperparathyroidism (Lemos MC &amp; Thakker RV Hum. Mutat. 2008 Jan; 29(1):22-32). Of note, this mutation is also designated as c.1546_1547insC, p.Arg521fsX15, and c.1561dup (p.Arg521fs) in the published literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130799.2:c.1546dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough031523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2470011" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="101438|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001248412" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="CG" referenceAllele="C" start="64572092" stop="64572092" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2905703" SubmissionDate="2020-12-30" DateLastUpdated="2021-01-26" DateCreated="2021-01-26">
        <ClinVarSubmissionID localKey="NM_130799.2:c.1546dup|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001476547" DateUpdated="2021-01-26" DateCreated="2021-01-26" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30324798</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29036195</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22470073</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21340156</ID>
          </Citation>
          <Comment>The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Found in at least one patient with expected phenotype for this gene, and found in general population data at a frequency that is consistent with pathogenicity.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130799.2:c.1546dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8819545</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5026731" SubmissionDate="2022-08-30" DateLastUpdated="2022-09-17" DateCreated="2022-09-17">
        <ClinVarSubmissionID localKey="NM_130799.2:c.1546dupC|MedGen:C0025267" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002570981" DateUpdated="2022-09-17" DateCreated="2022-09-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9463336</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11303512</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30339208</ID>
          </Citation>
          <Comment>Variant summary: MEN1 c.1546dupC (p.Arg516ProfsX15) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 2.1e-05 in 237028 control chromosomes. c.1546dupC has been reported in the literature as a common pathogenic mutation in numerous individuals affected with Multiple Endocrine Neoplasia Type 1 and was shown to segregate with disease (examples: Kytola_2001, Bassett_1998, Romanet_2019, etc). Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_130799.2:c.1546dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0025267" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11991162</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4016188" SubmissionDate="2024-01-24" DateLastUpdated="2024-02-20" DateCreated="2022-01-08">
        <ClinVarSubmissionID localKey="2352748|MedGen:CN235283" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002047850" DateUpdated="2024-02-20" DateCreated="2022-01-08" Type="SCV" Version="2" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The MEN1 c.1546dup; p.Arg516ProfsTer15 variant (rs767319284), also known as 1561dupC, 1650insC, 1656dupC, or 1657insC, is reported in the literature in multiple individuals and families affected with multiple endocrine neoplasia type 1 (Cardinal 2005, de Laat 2014, Ebeling 2004, Karageorgiadis 2015, Kytola 2001, Pieterman 2012). This variant is reported as pathogenic by multiple laboratories in ClinVar (Variation ID: 279852). This variant results in a premature termination codon in the last exon of the MEN1 gene. While this may not lead to nonsense-mediated decay, it is expected to create a truncated protein, and other downstream pathogenic truncating variants have been reported in families with multiple endocrine neoplasia type 1 (Cardinal 2005, Pieterman 2012). Based on available information, this variant is considered to be pathogenic. References: Cardinal JW et al. A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. J Med Genet. 2005 Jan;42(1):69-74. PMID: 15635078. de Laat JM et al. Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients. J Clin Endocrinol Metab. 2014 Sep;99(9):3325-33. PMID: 24915123. Ebeling T et al. Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations. J Clin Endocrinol Metab. 2004 Jul;89(7):3392-6. Karageorgiadis AS et al. Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it. J Clin Endocrinol Metab. 2015 Jan;100(1):141-8. PMID: 15240620. Kytola S et al. Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland. J Med Genet. 2001 Mar;38(3):185-9. PMID: 11303512. Pieterman CR et al. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg. 2012 Jun;255(6):1171-8. PMID: 22470073.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2024</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/xwiqgyug/arup_molecular_germline_variant_investigation_process_arup-info-0022_2024.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.64572099dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN235283" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023 ARUP ClinVar submission</SubmissionName>
          <SubmissionName>ARUP Molecular 2021</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9016818" SubmissionDate="2024-04-16" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="1246089|MONDO:0007540" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004832794" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="All of Us Research Program, National Institutes of Health" OrgID="509529" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9215689</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9463336</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11303512</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11579199</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12112656</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15240620</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15635078</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17623761</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17853334</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17879353</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20833329</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32299109</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34160414</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">35696052</ID>
          </Citation>
          <Comment>This variant inserts 1 nucleotide in exon 10 of the MEN1 gene, creating a frameshift and premature translation stop signal. This variant is also known as 1650insC, 1657insC, and c.1546_1547insC in the literature. While this variant is not expected to trigger nonsense-mediated decay, the truncated protein is expected to disrupt that C-terminus that interacts with different proteins and also contain a nuclear localization domain (PMID: 17879353). Similar truncation variants have been reported as disease-causing in ClinVar, suggesting that the C-terminus of MEN1 is important for function (variation ID: 201002, 200986, 200999, 988375, 988490, 988531). This variant is a common variant and has been proposed to be a mutation hotspot because it has been reported in dozens of individuals and families affected with MEN1 from different populations worldwide (PMID: 9215689, 9463336, 11579199, 11303512, 12112656, 15240620, 15635078, 17853334, 17623761, 17879353, 20833329, 32299109, 34160414, 35696052). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of MEN1 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>108544</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.64572099dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0007540" />
          </Trait>
        </TraitSet>
        <Comment>This study involves interpretation of variants in research participants for the purpose of population health screening. Participant phenotype was not available at the time of variant classification. Additional details can be found in publication PMID: 35346344, PMCID: PMC8962531</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB14382316</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9057099" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="76316114|Orphanet:ORPHA652" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004848077" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11303512</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24915123</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14985373</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9709921</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22470073</ID>
          </Citation>
          <Comment>The p.Arg521fs (as known as p.Arg516fs on transcript NM_130799.2) variant in MEN1 has been reported in &gt;20 individuals with familial hyperparathyroidism or multiple endocrine neoplasia type 1 and segregated in &gt;5 affected individuals from 1 Finnish family (The 1998, Kytola 2001, Warner 2004, de Laat 2014, Pieterman 2012). This variant has been reported in ClinVar (Variation ID# 279852) and was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 521 and leads to a premature termination codon 15 amino acids downstream. This termination codon occurs within the terminal 50 bases of the last exon and is more likely to escape nonsense mediated decay (NMD) and result in a truncated protein. In summary, this variant meets criteria to be classified as pathogenic for multiple endocrine neoplasia type 1 in an autosomal dominant manner. ACMG/AMP Criteria applied: PS4, PVS1_Strong, PM2, PP1_Moderate.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MEN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_130804.3:exon 11</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.10:g.64804620_64804621insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA652" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="38450" TraitType="Disease" MappingType="Name" MappingValue="CARCINOID TUMOR OF LUNG" MappingRef="Preferred">
        <MedGen CUI="C0280089" Name="Lung carcinoid tumor" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="642684" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9057099" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA652" MappingRef="Orphanet">
        <MedGen CUI="C0025267" Name="Multiple endocrine neoplasia, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9016818" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0007540" MappingRef="MONDO">
        <MedGen CUI="C0025267" Name="Multiple endocrine neoplasia, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2905703" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1220277" TraitType="Disease" MappingType="XRef" MappingValue="C0025267" MappingRef="MedGen">
        <MedGen CUI="C0025267" Name="Multiple endocrine neoplasia, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="38468" TraitType="Disease" MappingType="Name" MappingValue="MULTIPLE ENDOCRINE NEOPLASIA, TYPE I" MappingRef="Preferred">
        <MedGen CUI="C0025267" Name="Multiple endocrine neoplasia, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2470011" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4016188" TraitType="Disease" MappingType="XRef" MappingValue="CN235283" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1524308" TraitType="Disease" MappingType="XRef" MappingValue="C0025267" MappingRef="MedGen">
        <MedGen CUI="C0025267" Name="Multiple endocrine neoplasia, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1129376" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5026731" TraitType="Disease" MappingType="XRef" MappingValue="C0025267" MappingRef="MedGen">
        <MedGen CUI="C0025267" Name="Multiple endocrine neoplasia, type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

